scispace - formally typeset
Journal ArticleDOI

H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo.

Reads0
Chats0
TLDR
H6 is a novel and potent MDR reversal agent, which has the potential to be administered in combination with conventional anticancer drugs and demonstrates robust reversal activity against MDR in vitro and in vivo.
About
This article is published in Toxicology and Applied Pharmacology.The article was published on 2018-02-15. It has received 75 citations till now. The article focuses on the topics: Multiple drug resistance & P-glycoprotein.

read more

Citations
More filters
Journal ArticleDOI

Structural and functional aspects of P-glycoprotein and its inhibitors.

TL;DR: This review presents up‐to‐date information on the structural and functional aspects of P‐glycoprotein and its known inhibitors and provides some information on drug discovery approaches for candidate P‐gp inhibitors.
Journal ArticleDOI

Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells

TL;DR: Results indicated that CBD could induce G0–G1 phase cell cycle arrest and apoptosis by increasing ROS production, leading to the inhibition of SGC-7901 cell proliferation, thereby suggesting that CBD may have therapeutic effects on gastric cancer.
Journal ArticleDOI

A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.

TL;DR: PLQ/GA nanoparticles provide a synergistic strategy for effective targeted co-delivery of chemotherapeutic and antiangiogenic agents and reversing MDR and metastasis in breast cancer.
Journal ArticleDOI

Oxidation of multiple MiT/TFE transcription factors links oxidative stress to transcriptional control of autophagy and lysosome biogenesis.

TL;DR: It is shown that multiple MiT-TFE transcription factors including TFEB, TFE3 and MITF, which are master regulators of autophagy and lysosomal biogenesis, can be activated upon direct cysteine oxidation by ROS.
Journal ArticleDOI

Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis.

TL;DR: Withaferin A is a bioactive compound with a remarkable anti‐cancer effect derived from Withania somnifera, commonly known as ashwagandha, but the anti-cancer mechanisms of WA in glioblastoma multiforme (GBM) are still unclear.
References
More filters
Journal ArticleDOI

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

TL;DR: The LIGPLOT program automatically generates schematic 2-D representations of protein-ligand complexes from standard Protein Data Bank file input giving a simple and informative representation of the intermolecular interactions and their strengths, including hydrogen bonds, hydrophobic interactions and atom accessibilities.
Journal ArticleDOI

Targeting multidrug resistance in cancer

TL;DR: Various approaches to combating multidrug-resistant cancer are described, including the development of drugs that engage, evade or exploit efflux by ABC transporters.
Journal ArticleDOI

Mechanisms of cancer drug resistance

TL;DR: The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anti-cancer drugs from cells, but other mechanisms of resistance including insensitivity to drug-induced apoptosis and induction of drug-detoxifying mechanisms probably play an important role in acquired anticancer drug resistance as mentioned in this paper.
Journal ArticleDOI

The Human ATP-Binding Cassette (ABC) Transporter Superfamily

TL;DR: The current knowledge of the human ABC genes, their role in inherited disease, and understanding of the topology of these genes within the membrane are reviewed.
Journal ArticleDOI

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.

TL;DR: The development of new compounds and the re-evaluation of compounds originally designed for other targets as transport inhibitors of ATP-dependent drug efflux pumps are summarized.
Related Papers (5)